597 related articles for article (PubMed ID: 17336402)
21. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
23. Comparison of cytomegalovirus pp-65 antigenemia assay and plasma DNA correlation with the clinical outcome in transplant recipients.
de Oña M; Melón S; Galarraga MC; Palacio A; Lambert JL; Bernardo MJ; Rodríguez M; Gómez E
Transpl Int; 2005 Jan; 18(1):43-6. PubMed ID: 15612982
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
[TBL] [Abstract][Full Text] [Related]
25. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
26. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
[TBL] [Abstract][Full Text] [Related]
27. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
28. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
Pumannova M; Roubalova K; Vitek A; Sajdova J
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
[TBL] [Abstract][Full Text] [Related]
29. A quantitative test (HCMV-hybrid-capture(TM)) to detect human cytomegalovirus DNA in the blood of immunocompromised patients compared with antigenemia and polymerase chain reaction.
Lazzarotto T; Campisi T; Dal Monte P; Galli S; Spezzacatena P; Guglielmi P; Landini MP
New Microbiol; 1996 Jul; 19(3):193-201. PubMed ID: 8841034
[TBL] [Abstract][Full Text] [Related]
30. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
31. Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation.
Schröeder R; Michelon T; Fagundes I; Bortolotto A; Petry M; Lammerhirt E; Santos L; Cantarelli V; Keitel E; Garcia V; Neumann J
Transplant Proc; 2004 May; 36(4):891-3. PubMed ID: 15194306
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment.
Allice T; Cerutti F; Pittaluga F; Varetto S; Franchello A; Salizzoni M; Ghisetti V
J Virol Methods; 2008 Mar; 148(1-2):9-16. PubMed ID: 18045702
[TBL] [Abstract][Full Text] [Related]
33. Quantification of human cytomegalovirus DNA by a new capture hybrid polymerase chain reaction enzyme-linked immunosorbent assay in plasma and peripheral blood mononuclear cells of bone marrow transplant recipients.
Ziyaeyan M; Sabahi F; Alborzi A; Ramzi M; Mahboudi F; Pourabbas B; Kadivar M
Exp Clin Transplant; 2008 Dec; 6(4):294-300. PubMed ID: 19338492
[TBL] [Abstract][Full Text] [Related]
34. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
[TBL] [Abstract][Full Text] [Related]
35. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.
David-Neto E; Triboni AH; Paula FJ; Vilas Boas LS; Machado CM; Agena F; Latif AZ; Alencar CS; Pierrotti LC; Nahas WC; Caiaffa-Filho HH; Pannuti CS
Transplantation; 2014 Nov; 98(10):1077-81. PubMed ID: 24839894
[TBL] [Abstract][Full Text] [Related]
36. Comparison of ethylenediaminetetraacetic acid and sodium citrate as anticoagulants in collection of samples for cytomegalovirus pp65 antigen detection in renal transplant recipients with suspected cytomegalovirus disease.
Patnaik N; Ratho RK; Mishra B; Chakraborty A; Sakhuja VK
J Virol Methods; 2008 Feb; 147(2):319-21. PubMed ID: 17996957
[TBL] [Abstract][Full Text] [Related]
37. [Prognosis value of the pp65 antigenemia and semi-quantitative PCR in the detection of the CMV reactivation in bone marrow grafted patients].
Ksouri H; Lakhal A; Ben Amor R; Torjman L; Achour W; Ben Othmen T; Ladeb S; Abdelkefi A; Slim A; Abdeladhim A; Ben Hassen A
Bull Soc Pathol Exot; 2006 Jul; 99(3):155-9. PubMed ID: 16983816
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of cytomegalovirus quantification in blood by the R-gene real-time PCR test].
Marque-Juillet S; Touzard A; Monnier S; Fernand-Laurent C; Therby A; Rigaudeau S; Harzic M
Pathol Biol (Paris); 2010 Apr; 58(2):162-5. PubMed ID: 19854587
[TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
40. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
